非转移-话题@MedSci - 梅斯（MedSci）

#非转移#

46篇内容 | 1561人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819687, encodeId=74fc181968e06, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究, objectType=article, longId=202311, objectId=bf812023119e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf812023119e, replyNumber=0, likeNumber=72, createdTime=2021-04-11, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf812023119e, moduleTitle=Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bf812023119e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819683, encodeId=f7e2181968347, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=拜尔的雄激素受体拮抗剂Nubeqa在欧洲被授权，用于治疗非转移性前列腺癌, objectType=article, longId=191239, objectId=94ff191239b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94ff191239b4, replyNumber=0, likeNumber=55, createdTime=2020-10-11, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94ff191239b4, moduleTitle=拜尔的雄激素受体拮抗剂Nubeqa在欧洲被授权，用于治疗非转移性前列腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=94ff191239b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819681, encodeId=27611819681df, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间, objectType=article, longId=183719, objectId=f1bc183e1902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1bc183e1902, replyNumber=0, likeNumber=73, createdTime=2020-07-22, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1bc183e1902, moduleTitle=2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1bc183e1902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819679, encodeId=13dd18196e9b6, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Brit J Cancer：非转移前列腺癌预后研究, objectType=article, longId=180185, objectId=e147180185f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e147180185f8, replyNumber=0, likeNumber=57, createdTime=2020-08-02, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e147180185f8, moduleTitle=Brit J Cancer：非转移前列腺癌预后研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e147180185f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819680, encodeId=64741819680d9, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Ann Oncol：非转移去势抵抗性前列腺癌中阿帕鲁他胺和总体存活率研究, objectType=article, longId=182477, objectId=9fb91824e7c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fb91824e7c0, replyNumber=0, likeNumber=94, createdTime=2020-10-15, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fb91824e7c0, moduleTitle=Ann Oncol：非转移去势抵抗性前列腺癌中阿帕鲁他胺和总体存活率研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9fb91824e7c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819678, encodeId=351f18196e8b8, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=多拉米胺Darolutamide在欧盟申请上市，用于治疗非转移性去势抵抗性前列腺癌, objectType=article, longId=162125, objectId=bf0c162125cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf0c162125cc, replyNumber=0, likeNumber=71, createdTime=2019-07-03, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf0c162125cc, moduleTitle=多拉米胺Darolutamide在欧盟申请上市，用于治疗非转移性去势抵抗性前列腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bf0c162125cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819677, encodeId=2b3018196e7ba, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Darolutamide治疗非转移性去势抵抗性前列腺癌已向FDA滚动提交完成, objectType=article, longId=161512, objectId=f0b416151215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0b416151215, replyNumber=0, likeNumber=76, createdTime=2019-03-11, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0b416151215, moduleTitle=Darolutamide治疗非转移性去势抵抗性前列腺癌已向FDA滚动提交完成, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f0b416151215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819675, encodeId=66ce18196e540, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Stem Cell Res Ther：miR-508-5p通过靶向糖蛋白非转移性黑素瘤蛋白B对人牙髓干细胞牙源性分化的抑制作用, objectType=article, longId=158916, objectId=d3131589166d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3131589166d, replyNumber=0, likeNumber=54, createdTime=2019-12-27, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3131589166d, moduleTitle=Stem Cell Res Ther：miR-508-5p通过靶向糖蛋白非转移性黑素瘤蛋白B对人牙髓干细胞牙源性分化的抑制作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d3131589166d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819676, encodeId=770018196e630, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=darolutamide联合雄激素剥夺疗法在非转移性去势抵抗性前列腺癌中显著延长了PFS, objectType=article, longId=160341, objectId=61af160341ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61af160341ee, replyNumber=0, likeNumber=71, createdTime=2019-05-14, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61af160341ee, moduleTitle=darolutamide联合雄激素剥夺疗法在非转移性去势抵抗性前列腺癌中显著延长了PFS, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=61af160341ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819672, encodeId=e49f18196e215, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, objectType=article, longId=145555, objectId=1638145555dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1638145555dc, replyNumber=0, likeNumber=60, createdTime=2018-12-04, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1638145555dc, moduleTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1638145555dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819673, encodeId=00b418196e3b4, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=2018 CUA指南：非转移性肾细胞癌患者治疗后随访, objectType=article, longId=147550, objectId=562e14e55099, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=562e14e55099, replyNumber=0, likeNumber=29, createdTime=2018-11-18, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=562e14e55099, moduleTitle=2018 CUA指南：非转移性肾细胞癌患者治疗后随访, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=562e14e55099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819671, encodeId=189018196e199, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=FDA扩大了辉瑞/安斯泰来的Xtandi的适应症用以治疗非转移性前列腺癌, objectType=article, longId=144569, objectId=4e5f14456932, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e5f14456932, replyNumber=0, likeNumber=99, createdTime=2019-06-17, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e5f14456932, moduleTitle=FDA扩大了辉瑞/安斯泰来的Xtandi的适应症用以治疗非转移性前列腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4e5f14456932)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819674, encodeId=185f18196e452, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=名家视点 | 刘云鹏教授：后 TNM 时代，非转移性肠癌精准诊疗路在何方？, objectType=article, longId=152065, objectId=00f71520653d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f71520653d, replyNumber=0, likeNumber=52, createdTime=2019-01-10, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f71520653d, moduleTitle=名家视点 | 刘云鹏教授：后 TNM 时代，非转移性肠癌精准诊疗路在何方？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=00f71520653d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819670, encodeId=537218196e0f9, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=JAMA Oncol：脑洞大开：CT扫描肌肉和脂肪可预测非转移性乳腺癌患者生存, objectType=article, longId=136936, objectId=331e1369364c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=331e1369364c, replyNumber=0, likeNumber=62, createdTime=2018-11-04, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=331e1369364c, moduleTitle=JAMA Oncol：脑洞大开：CT扫描肌肉和脂肪可预测非转移性乳腺癌患者生存, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=331e1369364c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819669, encodeId=a827181966980, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Prostate：在非转移性去势难治性前列腺癌患者中，早期雄激素受体靶向药物治疗能够提高总生存, objectType=article, longId=136082, objectId=990613608223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990613608223, replyNumber=0, likeNumber=69, createdTime=2018-11-08, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990613608223, moduleTitle=Prostate：在非转移性去势难治性前列腺癌患者中，早期雄激素受体靶向药物治疗能够提高总生存, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=990613608223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819668, encodeId=ea5718196687f, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=J Urology：争议：高危非转移性肾癌需要行淋巴结清扫吗？, objectType=article, longId=127048, objectId=064b12e04864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=064b12e04864, replyNumber=0, likeNumber=75, createdTime=2018-09-26, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=064b12e04864, moduleTitle=J Urology：争议：高危非转移性肾癌需要行淋巴结清扫吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=064b12e04864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819667, encodeId=e20d181966e23, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=UROLOGY：非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案, objectType=article, longId=124016, objectId=891512401660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891512401660, replyNumber=0, likeNumber=56, createdTime=2018-01-25, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891512401660, moduleTitle=UROLOGY：非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=891512401660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819664, encodeId=8bd91819664ce, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=Gut：全基因组DNA甲基化分析揭示非转移性结直肠癌患者预后！, objectType=article, longId=118798, objectId=a8a4118e98dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8a4118e98dc, replyNumber=0, likeNumber=66, createdTime=2017-12-29, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8a4118e98dc, moduleTitle=Gut：全基因组DNA甲基化分析揭示非转移性结直肠癌患者预后！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a8a4118e98dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819662, encodeId=591118196627a, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=2017 IOF立场声明：非转移性前列腺癌患者脆性骨折的预防, objectType=article, longId=110304, objectId=e39a110304e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e39a110304e3, replyNumber=0, likeNumber=74, createdTime=2017-09-19, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e39a110304e3, moduleTitle=2017 IOF立场声明：非转移性前列腺癌患者脆性骨折的预防, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e39a110304e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819666, encodeId=5fdf181966638, content=<a href='/topic/show?id=b018996931d' target=_blank style='color:#2F92EE;'>#非转移#</a>, objectTitle=JAMA Oncology：全身炎症反应和肌肉减少症与非转移性结直肠癌预后的关系, objectType=article, longId=123646, objectId=7b131236466d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b131236466d, replyNumber=0, likeNumber=110, createdTime=2018-05-31, rootId=0, userName=cmj8wellington, userId=c689267, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b131236466d, moduleTitle=JAMA Oncology：全身炎症反应和肌肉减少症与非转移性结直肠癌预后的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7b131236466d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非转移

2020-05-29

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Eur Urol：恩杂鲁胺治疗的非转移去势抵抗性前列腺癌男性的前列腺特异性抗原进展研究

2021-04-11

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

拜尔的雄激素受体拮抗剂Nubeqa在欧洲被授权，用于治疗非转移性前列腺癌

2020-10-11

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间

2020-07-22

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Brit J Cancer：非转移前列腺癌预后研究

2020-08-02

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Ann Oncol：非转移去势抵抗性前列腺癌中阿帕鲁他胺和总体存活率研究

2020-10-15

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

多拉米胺Darolutamide在欧盟申请上市，用于治疗非转移性去势抵抗性前列腺癌

2019-07-03

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Darolutamide治疗非转移性去势抵抗性前列腺癌已向FDA滚动提交完成

2019-03-11

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Stem Cell Res Ther：miR-508-5p通过靶向糖蛋白非转移性黑素瘤蛋白B对人牙髓干细胞牙源性分化的抑制作用

2019-12-27

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

darolutamide联合雄激素剥夺疗法在非转移性去势抵抗性前列腺癌中显著延长了PFS

2019-05-14

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率

2018-12-04

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

2018 CUA指南：非转移性肾细胞癌患者治疗后随访

2018-11-18

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

FDA扩大了辉瑞/安斯泰来的Xtandi的适应症用以治疗非转移性前列腺癌

2019-06-17

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

名家视点 | 刘云鹏教授：后 TNM 时代，非转移性肠癌精准诊疗路在何方？

2019-01-10

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

JAMA Oncol：脑洞大开：CT扫描肌肉和脂肪可预测非转移性乳腺癌患者生存

2018-11-04

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Prostate：在非转移性去势难治性前列腺癌患者中，早期雄激素受体靶向药物治疗能够提高总生存

2018-11-08

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

J Urology：争议：高危非转移性肾癌需要行淋巴结清扫吗？

2018-09-26

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

UROLOGY：非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案

2018-01-25

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

Gut：全基因组DNA甲基化分析揭示非转移性结直肠癌患者预后！

2017-12-29

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

2017 IOF立场声明：非转移性前列腺癌患者脆性骨折的预防

2017-09-19

cmj8wellington (审核中...)

前往app查看评论内容

#非转移#

JAMA Oncology：全身炎症反应和肌肉减少症与非转移性结直肠癌预后的关系

2018-05-31

科室
- - 订阅+
  - 更多科室
工具
服务